By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – A Decode Genetics-led team has applied its genome-wide association study approach, which involves imputing some SNPs from Icelanders' genome sequence data, to find genetic variants contributing both to thyroid stimulating hormone levels and to risk of non-medullary thyroid cancer. The findings appeared online in Nature Genetics yesterday.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: swapping yeast genes with human orthologs to study conservation of function, and more.

Hong Kong is using DNA phenotyping to shame litterers.

A study appearing in Cell suggests some metastatic castration-resistant prostate cancer patients could benefit from PARP inhibitor therapy.

NIH's Francis Collins writes that scientific advances are poised to help populations all over the world, but more scientists are needed to keep the momentum.